基因疗法针对的是血脑屏障
Jakob Körbelin1, Adriana Arrulo2, Markus Schwaninger3
1Department of Oncology, Hematology and Bone Marrow Transplantation, UKE Hamburg-Eppendorf, Hamburg, Germany.
Vitamins and hormones
|July 19, 2024
概括
血脑屏障 (BBB) 阻碍了中枢神经系统的治疗. 在BBB中生产治疗性蛋白质.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 中枢神经系统 (CNS) 被血脑屏障 (BBB) 保护,该屏障限制了大型分子的通道.
- 这种障碍对提供抗体,蛋白质和病毒载体等治疗药物来治疗中枢神经系统疾病构成重大挑战.
研究的目的:
- 探索克服BBB的策略,以使中枢神经系统药物输送.
- 评估利用大脑内皮细胞作为治疗性蛋白质的现场生产场所的潜力.
主要方法:
- 审查BBB透的现有策略,包括使用像转移素受体 (TfR) 这样的配体进行受体介导的细胞转移.
- 直接在形成BBB的内皮细胞内产生治疗性蛋白质的概念探索.
主要成果:
- 受体介导的细胞转移显示出希望,但可能是复杂的实施.
- 在内皮细胞内生产治疗药物为直接中枢神经系统供应提供了一个潜在的更简单的替代方案.
结论:
- BBB是中枢神经系统治疗的关键障碍.
- BBB的内皮细胞为in situ治疗性蛋白质生产提供了可行的直接平台,促进中枢神经系统的输送.
关键词:
腺相关病毒的病毒.血液-大脑屏障是什么?内皮细胞是内皮细胞.脑内皮质变质症 (Endotheliopathy) 是一种内皮质变质症.基因治疗是一种基因疗法.失禁色素的颜料 失禁色素的颜料溶酶体储存障碍 溶酶体储存障碍更多相关视频
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
2.0K
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
3.6K
相关概念视频
00:49The Blood-brain Barrier
47.1K
Overview
47.1K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K